Undiagnosed morbidity in adult women with Turner's syndrome

被引:43
作者
Garden, AS
Diver, MJ
Fraser, WD
机构
[1] UNIV LIVERPOOL, ROYAL LIVERPOOL HOSP, DEPT CLIN CHEM, LIVERPOOL L7 8XP, MERSEYSIDE, ENGLAND
[2] UNIV LIVERPOOL, DEPT OBSTET & GYNAECOL, LIVERPOOL L69 3BX, MERSEYSIDE, ENGLAND
关键词
D O I
10.1046/j.1365-2265.1996.00849.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE Adult patients with Turner's syndrome are rarely followed up at specialist clinics after discharge from paediatric care but do have a predisposition to several long-term medical problems. We have assessed the undiagnosed morbidity that exists among adult women with Turner's syndrome. PATIENTS A group of 32 women (age range 17-52 years; mean 25 years) attending a specialist out-patient clinic. MEASUREMENTS Blood samples were obtained at the initial visit for lipid assessment, thyroid function, gonadal status and routine biochemical profile. Bone mineral density (BMD) was measured in 31 of the women. RESULTS Thirty-one women were receiving some form of oestrogen replacement. Two were receiving T4 therapy. In 50%, total cholesterol was greater than 5.2 mmol/l (range 3.4-9.3 mmol/l, mean 5.8 mmol/l) and 28% had an abnormality of thyroid function tests. Two women were newly diagnosed as hypothyroid, 6 had compensated hypothyroidism and one was under-replaced with T4. Lumbar spine BMD was below 100% of age matched reference range in 84% and below 75% in 26% of patients. Femoral neck BMD was below 100% of age matched reference range in 90% and below 75% in 10% of patients. CONCLUSIONS There is a high incidence of undiagnosed lipid, thyroid and bone mineral density abnormalities in the adult population with Turner's syndrome. Doctors caring for these women need to be aware of and look for the potential problems. Appropriate long-term treatment should be commenced to help prevent the development of lipid, skeletal and thyroid abnormalities which may cause these patients major problems in the future.
引用
收藏
页码:589 / 593
页数:5
相关论文
共 27 条
[1]   EXAGGERATED EFFECTS OF PROGESTOGEN ON UTERINE ARTERY PULSATILITY INDEX IN TURNERS-SYNDROME PATIENTS RECEIVING HORMONE REPLACEMENT THERAPY [J].
BILJAN, MM ;
TAYLOR, CT ;
MATIJEVIC, R ;
JONES, SV ;
GARDEN, AS ;
FRASER, WD ;
DIVER, MJ ;
KINGSLAND, CR .
FERTILITY AND STERILITY, 1995, 64 (06) :1104-1108
[2]   GONADAL DYSGENESIS WITH GRAVESS DISEASE [J].
BROOKS, WH ;
MEEK, JC ;
SCHIMKE, RN .
JOURNAL OF MEDICAL GENETICS, 1977, 14 (02) :128-129
[3]   Osteoporosis in Turner's syndrome and other forms of primary amenorrhoea [J].
Davies, MC ;
Gulekli, B ;
Jacobs, HS .
CLINICAL ENDOCRINOLOGY, 1995, 43 (06) :741-746
[4]  
FORD CE, 1959, LANCET, V1, P711
[5]   AGE-RELATED ANTITHYROID ANTIBODIES AND THYROID ABNORMALITIES IN TURNER SYNDROME [J].
GERMAIN, EL ;
PLOTNICK, LP .
ACTA PAEDIATRICA SCANDINAVICA, 1986, 75 (05) :750-755
[6]   SEX, PLASMA-LIPOPROTEINS, AND ATHEROSCLEROSIS - PREVAILING ASSUMPTIONS AND OUTSTANDING QUESTIONS [J].
GODSLAND, IF ;
WYNN, V ;
CROOK, D ;
MILLER, NE .
AMERICAN HEART JOURNAL, 1987, 114 (06) :1467-1503
[7]  
GOULD AL, 1993, CIRCULATION, V87, P700
[8]  
HALL JG, 1990, PEDIATR CLIN N AM, V37, P1421
[9]   TURNER SYNDROME - FINAL HEIGHT, GLUCOSE-TOLERANCE, BONE-DENSITY AND PSYCHOSOCIAL STATUS IN 25 ADULT PATIENTS [J].
HOLL, RW ;
KUNZE, D ;
ETZRODT, H ;
TELLER, W ;
HEINZE, E .
EUROPEAN JOURNAL OF PEDIATRICS, 1994, 153 (01) :11-16
[10]   AN ANALYSIS OF RANDOMIZED TRIALS EVALUATING THE EFFECT OF CHOLESTEROL REDUCTION ON TOTAL MORTALITY AND CORONARY HEART-DISEASE INCIDENCE [J].
HOLME, I .
CIRCULATION, 1990, 82 (06) :1916-1924